Chemoinformaics analysis of matricaria methyl ester
| Molecular Weight | 172.183 | nRot | 1 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 5 |
| Exact Molecular Weight | 172.052 | nRing | 0 |
| Solubility: LogS | -3.369 | nHRing | 0 |
| Solubility: LogP | 3.167 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.3083 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.331 |
| Synth | 3.677 |
| Natural Product Likeliness | 2.654 |
| NR-PPAR-gamma | 0.078 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.874 |
| CACO-2 | -4.321 |
| MDCK | 0.000108812 |
| BBB | 0.003 |
| PPB | 1.01798 |
| VDSS | 0.915 |
| FU | 0.0346455 |
| CYP1A2-inh | 0.983 |
| CYP1A2-sub | 0.67 |
| CYP2c19-inh | 0.915 |
| CYP2c19-sub | 0.69 |
| CYP2c9-inh | 0.896 |
| CYP2c9-sub | 0.088 |
| CYP2d6-inh | 0.62 |
| CYP2d6-sub | 0.103 |
| CYP3a4-inh | 0.846 |
| CYP3a4-sub | 0.259 |
| CL | 10.107 |
| T12 | 0.431 |
| hERG | 0 |
| Ames | 0.665 |
| ROA | 0.878 |
| SkinSen | 0.958 |
| Carcinogencity | 0.5 |
| EI | 0.968 |
| Respiratory | 0.495 |
| NR-Aromatase | 0.854 |
| Antiviral | No |
| Prediction | 0.737821 |